The Australian Organoid Facility develops scalable human organoid and 3D tissue models for disease modelling, drug screening and translational research, integrating automation, high-content imaging and quantitative analysis to improve reproducibility and impact.
I'm looking for
2 months ago
We seek partnerships with academia, biotech and pharma for sponsored research, co-development of organoid models, assay development, drug screening and grant-funded projects, particularly where human-relevant 3D models improve translational outcomes.
About
Nathan Gödde’s research focuses on the development, automation and standardisation of stem cell-derived organoid models for academic and industry applications. His work integrates laboratory automation, high-content imaging and quantitative analysis to improve reproducibility, scalability and data quality in complex 3D systems. He has applied organoid and tissue models across cancer biology, infectious disease and developmental biology, with a strong interest in building robust human-relevant platforms that reduce reliance on animal models. A central focus is advancing automated workflows and quality frameworks that support organoids as reliable tools for discovery science, drug screening and translational research.
Partnering listings
Learn more
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.